Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach 5mg dose of tirzepatide in the Mounjaro KwikPen contains 0.5ml of solution. That figure comes directly from the licensed product's specifications: every pre-filled Mounjaro pen holds four weekly doses totalling 2ml, so each injection — including the 5mg dose — delivers exactly 0.5ml. You don't draw up that volume yourself; the KwikPen is pre-set. Mounjaro is a prescription-only medicine, and the dose you use is determined by a prescriber following a clinical assessment, not by the volume in the pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture a small medical syringe marked up to 1ml, a single Mounjaro dose fills it exactly halfway. That's 0.5ml, roughly ten drops of water, delivered through a fine needle into the skin of your abdomen, thigh or upper arm. It's a small volume by any measure, and most people are surprised by just how little fluid is involved.
The reason the volume is fixed at 0.5ml across every Mounjaro strength is that the pen is engineered that way. A 2.5mg pen, a 5mg pen, a 12.5mg pen, each delivers four 0.5ml injections. What changes between strengths is the concentration of tirzepatide dissolved in that half-millilitre, not the fluid volume itself. The Mounjaro 5mg pen contains a higher concentration of tirzepatide per ml than the 2.5mg pen; the volume the device releases stays the same.
If you're curious how the 2.5mg starter dose compares in volume terms, the answer is exactly the same: 0.5ml at 2.5mg too. The NHS medicines information page for tirzepatide confirms the pen's design and general administration guidance, so that's a useful reference if you want to read the manufacturer's language directly.
A question our prescribers hear fairly regularly is whether someone can simply inject a bit more of a lower-strength pen to get a higher dose. The short answer is no, and it's worth understanding why. Each pen contains a fixed number of doses locked in by the device mechanism; there's no way to extract extra fluid or combine pens safely. More practically, the dose schedule exists for a clinical reason: tirzepatide titration is designed to let your digestive system settle at each level before stepping up.
Treatment typically begins at 2.5mg for the first four weeks (a tolerability phase rather than the treatment's main working dose) before a prescriber considers moving upward. Mounjaro's titration pathway continues through 5mg, 7.5mg, 10mg, 12.5mg and 15mg, each separated by roughly four weeks. How quickly you progress, whether you stay at 5mg longer, or whether you move to a higher strength, depends on how your body is responding and the judgement of your prescriber. The volume in the pen (always 0.5ml) has nothing to do with that decision.
For context on what 0.5ml looks like at 7.5mg (the next step on the schedule) the volume is identical. The difference is purely in the amount of active medicine packed into that fixed quantity of solution.
Because the KwikPen does the measuring for you, the practical questions shift to storage and technique. Mounjaro pens are kept refrigerated between 2°C and 8°C; the exact instructions for how long a pen may be kept at room temperature, and what to do if it's been out of the fridge, are set out in the Patient Information Leaflet and the NHS tirzepatide medicines page. Always follow those instructions rather than general advice online, because the window is specific to the product.
When you're ready to inject, you rotate the injection site each week (abdomen, front of the thigh, or outer upper arm) to reduce the chance of skin reactions. The needle goes in at a 90-degree angle, the button is pressed until the injection indicator confirms delivery, and then the needle is held in place for a count of ten before withdrawing. Technique matters more than volume here; the pen takes care of dispensing the 0.5ml reliably every time.
It's also worth knowing that Mounjaro is a Black Triangle (▼) medicine, meaning it's under additional monitoring by the MHRA. If you notice anything unexpected after your injection, you can report it through the Yellow Card scheme, that's how post-market safety data is gathered in the UK, and reports from patients count.
Understanding that every Mounjaro strength delivers 0.5ml per injection is genuinely useful, it removes a source of confusion for people switching strengths or reading forum posts where someone assumes a bigger volume means a stronger dose. It doesn't. The pen at 15mg looks and feels the same in your hand as the 5mg version and delivers the same half-millilitre. What has changed is the concentration, and with it, the clinical effect.
If you're thinking about what dose might be right for you, or whether Mounjaro is suitable in the first place, that's a conversation worth having with a prescriber rather than working backward from the numbers on the pen. You can read about the broader treatment options on our weight loss overview, and if you're also wondering how many ml 10mg of tirzepatide works out to, the answer follows the same logic as every other strength on the schedule. The volume question is a good one to have answered early; the clinical questions come next.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.